Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: Effect of corticosteroids

Journal of Hepatology

Volumn 32, Issue 4, 2000, Pages 579-586

  Taïeb, Julien ^a,b,c   Mathurin, Philippe ^b,c   Elbim, Carole ^a   Cluzel, Philippe ^b   Arce Vicioso, Montserrat ^a   Bernard, Brigitte ^b   Opolon, Pierre ^b   Gougerot Pocidalo, Marie Anne ^a   Poynard, Thierry ^b,c   Chollet Martin, Sylvie ^a,d  

^a BICHAT HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CNRS   (France)

^d Sylvie Chollet Martin   (France)

Author keywords

Alcoholic hepatitis; Corticosteroid; IL 10; IL 8; L selectin; Neutrophils; Oxidative burst; 2 integrin

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 10; INTERLEUKIN 8; SELECTIN;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CELL FUNCTION; CELL MIGRATION; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; LIVER BIOPSY; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; STEROID THERAPY;

EID: 0342368653     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80219-6     Document Type: Article

References (39)

1. Maddrey WC. Alcoholic hepatitis: pathogenesis and approaches to treatment. Scand J Gastroenterol. 25:1990;118-130.
2. Sauer A, Hartung T, Aigner J, Wendel A. Endotoxin-inducible granulocyte-mediated hepatotoxicity requires adhesion and serine protease release. J Leukoc Biol. 60:1996;633-643.
3. Lands W. Cellular signals in alcohol-induced liver injury: a review. Alcohol Clin Exp Res. 19:1995;928-938.
4. Huang Y, Chan C, Wu J, Pai C, Chao Y, Lee S. Serum levels of IL8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol. 24:1996;377-384.
5. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF. Plasma tumor necrosis factor α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res. 14:1990;255-259.
6. Sheron N, Bird G, Koskinas J, Portmann B, Lindley I, Williams R. Circulating and tissue levels of the neutrophil chemotaxin IL8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology. 18:1993;41-46.
7. Van der Poll T, de Waal Malefyt R, Coyle S, Lowry S. Anti-inflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble IL1 receptor type II, IL10 and IL13. J Infect Dis. 175:1997;118-122.
8. Ley K, Tedder T. Leukocyte interactions with vascular endothelium. J Immunol. 155:1995;525-528.
9. Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood. 64:1984;959-963.
10. Carithers RL, Herlong F, Diehl AM, Shaw EW, Combes B, Fallon HJ, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 110:1989;685-690.
11. Imperiale TF, McCullough AJ. Do cortisteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med. 113:1990;299-307.
12. Ramond MJ, Poynard T, Rueff B, Mathurin P, Theodore C, Chaput JC, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 326:1992;507-512.
13. Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedossa P, Erlinger S, et al. Survival and prognostic factors in patients with severe biopsy-proven alcoholic hepatitis treated by prednisolone: randomized trial, new cohort, and simulation. Gastroenterology. 110:1996;1847-1853.
14. Reglier H, Arce-Vicioso M, Fay M, Gougerot Pocidalo MA, Chollet Martin S. Lack of IL10 and IL13 production by human PMN. Cytokine. 22:1998;217-224.
15. Elbim C, Chollet-Martin S, Bailly S, Hakim J, Gougerot-Pocidalo MA. Differential priming effect of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun. 62:1994;2195-2202.
16. Ohlinger W, Dinges HP, Zatloukal K, Mair S, Gollowitsch F, Denk H. Immunohistochemical detection of TNFα, other cytokines and adhesion molecules in human liver with alcoholic hepatitis. Virchows Arch. 423:1993;169-176.
17. Ho J, Buchweitz J, Roth R, Ganey P. Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. J Leukoc Biol. 59:1996;716-724.
18. Jaeschke H, Smith CW, Clemens M, Ganey P, Roth R. Mechanism of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol. 139:1996;213-226.
19. Plusa S, Webster N, Primrose J. Obstructive jaundice causes reduced expression of PMN leukocytes adhesion molecules and a depressed response to bacterial wall products in vitro. Gut. 38:1996;784-787.
20. Spitzer JA, Zhang P, Mayer AMS. Functional characterization of peripheral circulating and liver recruited neutrophils in endotoxic rats. J Leukoc Biol. 56:1994;166-173.
21. Zhang P, Spitzer JA. Acute ethanol administration modulates leukocyte actin polymerization in endotoxic rats. Alcohol Clin Exp Res. 21:1997;779-783.
22. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot Pocidalo MA. Interaction between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med. 153:1996;594-601.
23. Gainet J, Chollet-Martin S, Brion M, Hakim J, Gougerot-Pocidalo MA, Elbim C. Interleukin-8 production by polymorphonuclear neutrophils in patients with rapidly progressive periodontitis: an amplifying loop of neutrophil activation. Lab Invest. 78:1998;755-762.
24. Bautista A. Chronic alcohol intoxication induces hepatic injury through enhanced MIP-2 production and ICAM-1 expression in the liver. Hepatology. 25:1997;335-342.
25. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, Bedossa P. In situ detection of lipid peroxydation by products in chronic liver disease. Hepatology. 26:1997;135-142.
26. Deforge L, Preston A, Takeushi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem. 268:1993;25568-25576.
27. Caudhri G, Clark I. Reactive oxygen species facilitate the in vitro LPS-induced release of tumor necrosis factor. J Immunol. 143:1989;1290-1294.
28. Rodeberg DA, Bass RC, Alexander JW, Warden GD, Babcock GF. Neutrophils from burn patients are unable to increase the expression of CD11b/CD18 in response to inflammatory stimuli. J Leukoc Biol. 61:1997;575-582.
29. Zhang P, Bagby GJ, Xie M, Stoltz DA, Summer WR, Nelson S. Ethanol inhibits neutrophil β2-integrin expression and phagocytosis during endotoxemia. Alcohol Clin Exp Res. 22:1998;135-141.
30. Simonet S, Hughes T, Nguyen H. Long-term impaired neutrophil migration in mice overexpressing human IL-8. J Clin Invest. 94:1994;1310-1319.
31. Seitz M, Loetscher P, Dewald B, Towbin H, Gallati H, Baggiolini M. IL-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol. 25:1995;1129-1133.
32. Louis H, Lemoine O, Peny MO, Quertinmont E, Fokan D, Goldman M, et al. Production and role of interleukin 10 in concanavalin A induced hepatitis in mice. Hepatology. 25:1997;1382-1389.
33. Louis H, Lemoine O, Peny MO, Gulbis B, Nisol F, Goldman M, et al. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology. 112:1997;935-942.
34. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Deviere J. Role of defective monocyte IL-10 release in TNFα overproduction in alcoholic cirrhosis. Hepatology. 22:1995;1436-1439.
35. Roilides E, Uhlig K, Venzon D, Pizzo P, Walsh T. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by G-CSF and IFN-gamma. Infect Immun. 61:1993;4870-4877.
36. Visser J, Boxel-Dezaire A, Methorst D, Brunt T, de Kloet ER, Nagelkerken L. Differential regulation of IL-10 and IL-12 by glucocorticoids in vitro. Blood. 91:1998;4255-4264.
37. Wan S, Le Clerc JL, Schmartz D, Devière J, Desmet JM, Vincent JL. Hepatic release of IL-10 during cardiopulmonary bypass in steroid pretreated patients. Am Heart J. 133:1997;335-339.
38. Chernoff A, Granowitz E, Shapiro L, Vannier E, Lonneman G, Angel JB, et al. A randomized control trial of IL10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol. 154:1995;5492-5499.
39. Van Deventer S, Elson C, Fedorak R. Multiple doses of intraveinous IL-10 in steroid-refractory Crohn disease. Gastroenterology. 113:1997;383-389.